BioCryst Pharmaceuticals logo
BioCryst Pharmaceuticals BCRX
$ 7.53 1.89%

Quarterly report 2024-Q3
added 11-05-2024

report update icon

BioCryst Pharmaceuticals EV/EBITDA Ratio 2011-2024 | BCRX

Annual EV/EBITDA Ratio BioCryst Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-13.8 -8.2 -2.93 -9.96 -6.82 -9.85 -13 -14.4 -19.1 -2.77 -3.52

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-2.77 -19.1 -9.49